LIPEDEMA

What Is Lipedema?

A genuine medical diagnosis—not a consequence of lifestyle.

Lipedema is a chronic, progressive and often overlooked disorder of subcutaneous adipose tissue that almost exclusively affects women. It is characterised by a disproportionate accumulation of fatty tissue in the limbs—most often the legs, but sometimes the arms—which causes problems including pain, tenderness to touch, swelling and a tendency to bruise.

Although it is estimated to affect 11% of adult women in the Western world, lipedema remains one of the most frequently overlooked conditions in medicine. On average, a woman with lipedema waits more than 11 years for a correct diagnosis; the initial advice is often simply to lose weight or exercise more.

Lipedema is not ordinary weight gain or the result of lifestyle; it is a complex medical condition associated with hormonal and genetic factors. In January 2022, the World Health Organization (WHO) formally recognised lipedema as a distinct disease. It involves changes in the biology of adipose tissue and in the vascular and lymphatic systems, and can have a major impact on women’s quality of life, mobility, self-confidence and everyday well-being.

Estimated to affect 11% of adult women in the Western world

Officially recognised as a distinct disease (ICD-11) since January 2022

Average time to an accurate diagnosis: more than 11 years from the onset of first symptoms

Causes pain, tenderness, swelling
and bruising

Responds poorly to
conventional weight-loss
methods and exercise

Disease onset is often associated with hormonal transitions such as puberty, pregnancy and menopause

Lipedema was first described by physicians Allen and Hines at the Mayo Clinic in 1940. For almost eight decades, it was poorly researched and often mistaken for obesity or lymphedema. For many women, this meant years—sometimes decades—of misdiagnosis, ineffective advice and messages implying they were to blame for their condition.

Major changes in care have occurred primarily over the past decade. On 1 January 2022, the World Health Organization (WHO) formally recognised lipedema as a distinct clinical entity and assigned it ICD-11 code EF02.2. This recognition fundamentally changed how the condition is diagnosed and treated around the world, confirming what patients had long known: it is a real disease with a real biological basis.

Lipedema affects an estimated 10–18% of adult women in the Western world—more than many well-known conditions such as multiple sclerosis or Parkinson’s disease. Yet it often remains unrecognised, with the average delay to diagnosis exceeding 11 years.

During this time, women commonly see numerous specialists, receive advice that does not help, and feel dismissed and misunderstood. Gradually, they lose trust in their own perception of their body. This is not their failure—it is a failure of awareness.

Most patients spend years looking for answers despite a healthy lifestyle, regular exercise and many attempts to lose weight. Because lipedema can resemble excess body weight in appearance, many hear the same message year after year: “You need to lose weight.” Yet lipedema-affected adipose tissue cannot be substantially reduced through dieting and physical activity alone.

This does not mean that a healthy lifestyle is unimportant—on the contrary. Appropriate nutrition, physical activity and other conservative measures for managing lipedema can have a significant effect on well-being and may slow the progression of the condition. Lipedema nevertheless requires expert, targeted specialist care. 

In Slovenia and the wider region, access to specialist diagnosis and treatment of lipedema was extremely limited for a long time. Our centre exists to change that—bringing international-level expertise to patients without the need to travel abroad.

Our clinical practice is based on the latest German lipedema guidelines from 2024—the current gold standard for the care and treatment of lipedema in Europe. The guidelines include 60 evidence-based recommendations on diagnosis and conservative and surgical treatment, ensuring care in line with current European standards.

Every consultation is delivered with specialist expertise, without judgement and with one aim: to establish an accurate diagnosis and map out a clear, individual route to treatment. Successful lipedema care requires precise diagnosis, a deep understanding of the condition and an approach tailored to each patient; long-term outcomes and quality of life depend on it.